Reports for JAMP PHARMA CORPORATION
Company Name
JAMP PHARMA CORPORATION
Totals |
||
Shortage reports |
527 |
|
| Actual shortage: | 137 (26%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (0%) | |
| Resolved: | 389 (74%) | |
Discontinuation Reports |
14 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 14 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
125 (23%) |
|
Overdue reports |
96 (70%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-10-15 | 2019-07-08 | 64233 |
| JAMP-CIPROFLOXACIN | 250MG | TABLET | Resolved | 2019-10-11 | 2020-04-29 | 96133 |
| JAMP-LEVETIRACETAM | 250MG | TABLET | Resolved | 2021-12-21 | 2022-04-06 | 151699 |
| JAMP-LEVETIRACETAM | 250MG | TABLET | Resolved | 2022-07-19 | 2024-04-17 | 164982 |
| JAMP-AMOXICILLIN | 250MG | CAPSULE | Resolved | 2023-01-18 | 2023-02-20 | 181443 |
| JAMP-AMOXICILLIN | 250MG | CAPSULE | Resolved | 2023-01-18 | 2023-05-02 | 181446 |
| JAMP CEPHALEXIN SUSPENSION | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-06-27 | 2024-02-27 | 196741 |
| JAMP CEPHALEXIN SUSPENSION | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-06-27 | 2024-02-27 | 196744 |
| JAMP-URSODIOL | 250MG | TABLET | Actual shortage | 2023-10-18 | 2024-03-12 | 207298 |
| JAMP-URSODIOL | 250MG | TABLET | Actual shortage | 2023-10-18 | 2024-03-12 | 207301 |
| JAMP GEFITINIB | 250MG | TABLET | Resolved | 2023-10-18 | 2024-02-05 | 207314 |
| JAMP-MYCOPHENOLATE CAPSULES | 250MG | CAPSULE | Resolved | 2024-02-07 | 2024-03-18 | 218727 |
| JAMP LEVETIRACETAM TABLETS | 250MG | TABLET | Resolved | 2024-03-30 | 2024-04-29 | 223970 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Resolved | 2017-09-29 | 2018-05-02 | 23905 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Resolved | 2017-09-29 | 2018-05-19 | 23918 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Resolved | 2019-10-07 | 2022-09-09 | 95704 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Resolved | 2019-10-07 | 2022-09-09 | 95710 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 25MG 300MG | TABLET | Resolved | 2017-03-27 | 2017-08-08 | 4434 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 25MG 300MG | TABLET | Resolved | 2017-03-27 | 2017-08-08 | 4444 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 25MG 300MG | TABLET | Actual shortage | 2019-10-11 | 2021-04-05 | 96186 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113293 |
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113296 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113299 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113302 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168995 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168998 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168987 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168990 |
| JAMP-ALPRAZOLAM | 1MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113305 |
| JAMP-SILDENAFIL | 25.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169003 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168981 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168984 |
| JAMP-ALPRAZOLAM | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113308 |
| JAMP-SILDENAFIL | 50.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169006 |
Showing 1 to 14 of 14